We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
-16.56%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$205B
AUM Growth
-$58.3B
Cap. Flow
-$4.48B
Cap. Flow %
-2.18%
Top 10 Hldgs %
21.11%
Holding
3,330
New
90
Increased
1,600
Reduced
1,393
Closed
130

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.04B
2
UNH icon
UnitedHealth
UNH
+$428M
3
MSFT icon
Microsoft
MSFT
+$410M
4
BAC icon
Bank of America
BAC
+$374M
5
BA icon
Boeing
BA
+$332M

Sector Composition

Rank Sector Weight
1 Technology 22.25%
2 Healthcare 14.77%
3 Financials 12.79%
4 Consumer Discretionary 10.52%
5 Communication Services 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AKRX
2826
DELISTED
Akorn Inc
AKRX
$423K ﹤0.01%
753,290
+45,130
+6% +$52.3K
GWRS icon
2827
Global Water Resources
GWRS
$219M
$422K ﹤0.01%
41,450
-75
-0.2% -$921
ISTR icon
2828
Investar Holding Corp
ISTR
$414M
$419K ﹤0.01%
32,823
-12
-0% -$244
RVSB icon
2829
Riverview Bancorp
RVSB
$108M
$419K ﹤0.01%
83,562
+6,998
+9% +$46.8K
ZYNE
2830
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$419K ﹤0.01%
109,544
-266
-0.2% -$1.24K
PINS icon
2831
Pinterest
PINS
$13.4B
$417K ﹤0.01%
+26,986
New +$525K
SOLY
2832
DELISTED
Soliton, Inc.
SOLY
$416K ﹤0.01%
51,365
-30,138
-37% -$340K
JAX
2833
DELISTED
J. Alexander's Holdings, Inc.
JAX
$416K ﹤0.01%
108,538
+2,364
+2% +$19.3K
MAV
2834
DELISTED
Pioneer Municipal High Income Advantage Fund
MAV
$414K ﹤0.01%
40,709
CRNX icon
2835
Crinetics Pharmaceuticals
CRNX
$8.92B
$413K ﹤0.01%
28,050
-191
-0.7% -$3.92K
SYRE icon
2836
Spyre Therapeutics
SYRE
$9.25B
$413K ﹤0.01%
3,544
-14
-0.4% -$2.38K
UUUU icon
2837
Energy Fuels
UUUU
$3.53B
$413K ﹤0.01%
349,358
-335
-0.1% -$470
ITRN icon
2838
Ituran Location and Control
ITRN
$1.05B
$412K ﹤0.01%
29,021
-18,046
-38% -$397K
DSKE
2839
DELISTED
Daseke, Inc. Common Stock
DSKE
$410K ﹤0.01%
292,339
-273,115
-48% -$805K
ARA
2840
DELISTED
American Renal Associates Holdings, Inc
ARA
$409K ﹤0.01%
61,794
-72
-0.1% -$628
FVCB icon
2841
FVCBankcorp
FVCB
$333M
$405K ﹤0.01%
37,954
+16
+0% +$198
RICK icon
2842
RCI Hospitality Holdings
RICK
$215M
$405K ﹤0.01%
40,609
+3,627
+10% +$64.6K
FRGI
2843
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
$405K ﹤0.01%
100,546
+5,035
+5% +$44K
STRO icon
2844
Sutro Biopharma
STRO
$421M
$403K ﹤0.01%
3,944
+1,220
+45% +$128K
ESSA
2845
DELISTED
ESSA Bancorp
ESSA
$401K ﹤0.01%
29,401
-63
-0.2% -$1.01K
FRBK
2846
DELISTED
Republic First Bancorp Inc
FRBK
$400K ﹤0.01%
182,769
+246
+0.1% +$777
FCBP
2847
DELISTED
First Choice Bancorp Common Stock
FCBP
$399K ﹤0.01%
26,576
+604
+2% +$13.6K
CRD.A icon
2848
Crawford & Co Class A
CRD.A
$669M
$398K ﹤0.01%
55,169
+14,336
+35% +$123K
CSLT
2849
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$396K ﹤0.01%
548,017
+207,700
+61% +$231K
BELFB
2850
Bel Fuse Inc Class B
BELFB
$4.21B
$394K ﹤0.01%
40,453
+2,722
+7% +$39.6K

Similar funds

Nuveen's Q1 2020 Portfolio in Review

As of Q1 2020, Nuveen held 3,330 positions worth $205B, down 22% from $264B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Nuveen's Q1 2020 filing shows 90 new, 1,600 increased, 1,393 reduced and 130 closed positions. Its largest new stake was Reynolds Consumer Products: 1,948,067 shares worth $56.8M. The largest sale was Apple, an estimated $1.04B.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Nuveen's largest Q1 2020 buy was Reynolds Consumer Products: 1,948,067 shares worth $56.8M.
  • Nuveen added most to Intel in Q1 2020, an estimated $723M increase.
  • Nuveen's biggest Q1 2020 reduction was Apple, cutting an estimated $1.04B.
  • Nuveen fully exited Liberty Property Trust in Q1 2020, selling an estimated $64M.
  • Nuveen's ten largest holdings make up 21% of its $205B portfolio in Q1 2020.
  • Nuveen opened 90 new positions and closed 130 in Q1 2020.
  • Nuveen's portfolio value fell 22% quarter-over-quarter to $205B.

Based on Nuveen's 13F filing for Q1 2020, filed 14 May 2020.